Key points are not available for this paper at this time.
ctDNA analysis enables detection of MRD and predicts relapse after definitive treatment for solid cancers, thereby promising to revolutionize personalization of adjuvant and consolidation therapies.
Moding et al. (Tue,) studied this question.